Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Caspase-1 protein governs the body inflammatory response

13.12.2007
What happens when bacteria infect the human body?

In an attempt to shed light on this process, Dr. Maya Saleh, researcher at the critical care division and the centre for the study of host resistance of the McGill University Health Centre (MUHC) Research Institute, describes previously unsuspected metabolic pathways involved in the inflammatory response. This discovery could lead to many potential benefits, particularly for the treatment of sepsis: infections that spread to the blood and deteriorates into a whole-body inflammatory state.

Her study is published in the Journal of Biological Chemistry. Because of the high quality of the research, this article was selected as a "Paper of the Week" for the December 14, 2007 issue of the journal, a distinction awarded to only one percent of its publications.

One of the body's first defenses against a bacterial infection is the activation of pathogen-eating cells called macrophages, which ingest the bacteria. This ingestion activates a protein inside the macrophage called Caspase-1. Dr. Saleh's study shows that Caspase-1 is the starting point for many metabolic reactions that, together, lead to the death of the macrophage and activate the rest of the immune system.

One of the roles of Caspase-1 in inflammation has been known for many years, namely that it activates immune system messengers called cytokines, which in turn activate the body's entire defense mechanism. But we now know this is not its sole function: "Our study demonstrates that Caspase-1 also causes the death of the macrophage by destroying some of the cell's basic structures and by blocking many metabolic pathways. The main pathway it blocks is glycolysis, or the production of energy through the breakdown of glucose," said Dr. Saleh, who is also an assistant professor in the faculty of medicine at the McGill University.

This finding opens new doors for fundamental research. Previous results suggested that Caspase-1 is also involved in fatal respiratory arrest that can occur during septic shock. Further research will be required to determine if that blockade of glycolysis by caspase-1 is a contributing factor.

This study could also have an important impact on the applied research of pharmaceutical companies. Currently, most anti-inflammatory drugs prescribed to fight sepsis target cytokines. "We know empirically that the effect of medications that target cytokines during sepsis is limited; our study demonstrates that Caspase-1 would be a more effective target", added Dr. Saleh. Since sepsis is no longer considered simply as a "cytokine storm", but as a more complex network of metabolic reactions, our vision of how to fight it needs to evolve accordingly.

The Research Institute of the McGill University Health Centre (RI MUHC) is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, a university health center affiliated with the Faculty of Medicine at McGill University. The institute supports over 500 researchers, nearly 1000 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge.

For more information please contact:

Isabelle Kling
Communications Coordinator (research)
MUHC Public Relations and Communications
(514) 934-1934 #36419
isabelle.kling@muhc.mcgill.ca

Isabelle Kling | MUHC
Further information:
http://www.muhc.ca/research

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>